If this occurs, slight dose adjustment (increasing by 50mcg if not already at 500mcg) may help
The difference between those outcomes and what patients experience at Perfect B is the medical infrastructure around the peptide: the intake that identifies contraindications, the baseline documentation that creates an honest reference point, the 503A compounding that ensures the compound is what it claims to be, and the APRN evaluation that adjusts the protocol when response is faster or slower than expected
Questions remain about long-term adherence, weight regain after discontinuation of treatment, and the functional implications of the loss of muscle and bone mass
On September 22, 2023, a warning about the risk of Ileus was added to Ozempics label
The study, Central nervous system uptake of intranasal glutathione in Parkinsons disease, was published in the journal NPJ Parkinsons Disease